ACE-920

N/A

Report date: 2025/02/01 20:00:06

Base Information

Drug NameACE-920

Drug Alias Namerecombinant ACE-527 enterotoxigenic E coli (ETEC) strain vaccine expressing ACE-393 C jejuni antigen (ACE BioSciences)Campylobacter/ETEC combination vaccine(ACE BioSciences)ACE-920

ClassificationVaccines > Development/production technology > Live attenuated vaccineVaccines > Application > Prophylactic vaccine

Mechanisms of ActionImmunomodulators

TargetsNot applicable

Therapy Area/IndicationsEscherichia coli InfectionsCampylobacter Infections

Global Approved IndicationsN/A

Approved Indications in ChinaN/A

Original Approved Country/TerritoryN/A

Original Approved DateN/A

Country/TerritoryDenmark

CombinationsNo

Global Highest StatusDiscontinued (Preclinical)

Highest Status in ChinaN/A

Originator CompaniesAce Biosciences

China Registration ClassN/A

Develop Information

Active CompaniesN/A

Inactive CompaniesAce Biosciences Td Vaccines A/S

Active IndicationsN/A

Inactive IndicationsEscherichia coli InfectionsCampylobacter Infections

Other Information

ATC CodeN/A